We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

NVO

62.62000 USD
0.54
0.87%
Last update Apr 28, 3:59 PM EDT
Pre-market
Day range
61.97000
63.25
Previous close
62.080002
Open
62.19000
Access this stock data via API
Subscribe
Novo Nordisk A/S Sponsored ADR
62.62
0.54
0.87%

Overview

Description

Novo Nordisk A/S Sponsored ADR represents Novo Nordisk A/S, a global healthcare company with a strong focus on diabetes care. As a sponsored American Depositary Receipt (ADR), it allows U.S. investors to purchase shares in Novo Nordisk, which is headquartered in Denmark, while trading on American stock exchanges. Novo Nordisk is renowned for its leadership in the production and innovation of insulin therapies and devices, catering primarily to individuals with diabetes. Beyond diabetes care, the company also makes significant contributions to the treatment of hemophilia, growth disorders, and obesity. In the global pharmaceutical industry, Novo Nordisk stands out for its commitment to research and development, particularly in metabolic therapies. The ADR structure facilitates the presence of Novo Nordisk in international markets by simplifying foreign investment and provides liquidity for investors seeking exposure to a leading player in the healthcare sector focused on chronic disease management.

About

CEO
Mr. Lars Fruergaard Jorgensen
Employees
76302
Address
Novo Alle 1
Bagsvaerd, 2880
Phone
45 44 44 88 88
Website
Instrument type
Depositary receipt
Sector
Healthcare
Industry
Drug Manufacturers - General
Country
United States
MIC code
XNYS
Pre-market

Exchange is currently open for pre-market.
Main market opens in 5 hours 2 minutes

04:27
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).